Explore 3 Stock Ideas & Industry Insights Download Free Report

18889881171
Shopping Cart 0
countryflagUS
Login

Encompass Health Corp

Healthcare US EHC

101.11USD
-2.9(2.79%)

Last update at 2026-06-08T20:00:00Z

Day Range

101.05103.86
LowHigh

52 Week Range

92.59127.51
LowHigh

Fundamentals

  • Previous Close 104.01
  • Market Cap10340.30M
  • Volume734943
  • P/E Ratio19.17
  • Dividend Yield0.68%
  • EBITDA1381.00M
  • Revenue TTM5935.20M
  • Revenue Per Share TTM59.06
  • Gross Profit TTM 2564.90M
  • Diluted EPS TTM5.36

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Analyst Recommendations

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Income before tax 953.00M 749.60M 607.20M 450.80M 657.20M
Minority interest -192.90000M -140.90000M -107.60000M -94.90000M -105.00000M
Net income 566.20M 455.70M 352.00M 271.00M 412.20M
Selling general administrative 236.20M 266.50M 201.70M 2602.30M 3164.00M
Selling and marketing expenses - - 56.30M - -
Gross profit 1289.30M 2233.20M 1982.80M 4146.50M 4912.30M
Reconciled depreciation 327.90M 299.60M 267.10M 243.60M 256.60M
Ebit 1076.20M 887.00M 731.80M 627.90M 822.80M
Ebitda 1404.10M 1186.60M 1005.70M 871.50M 1079.40M
Depreciation and amortization 327.90M 299.60M 273.90M 243.60M 256.60M
Non operating income net other - - - - 15.30M
Operating income 1053.10M 864.50M 1724.80M 627.90M 822.80M
Other operating expenses 4882.10M 4508.70M 3076.40M 3718.40M 4315.10M
Interest expense 123.20M 137.40M 143.50M 175.70M 164.60M
Tax provision 192.90M 150.20M 126.90M 100.10M 139.60M
Interest income 118.90M 134.40M 140.30M 172.80M 160.60M
Net interest income -123.20000M -137.40000M -146.10000M -175.70000M -164.60000M
Extraordinary items -1.00000M -2.80000M -12.00000M 13.90M -0.40000M
Non recurring - - - - -
Other items - - - - -
Income tax expense 192.90M 150.20M 132.20M 100.10M 139.60M
Total revenue 5935.20M 5373.20M 4801.20M 4348.60M 5121.60M
Total operating expenses 236.20M 1368.70M 258.00M 3516.30M 4105.80M
Cost of revenue 4645.90M 3140.00M 2818.40M 202.10M 209.30M
Total other income expense net -100.10000M -114.90000M -1117.60000M -177.10000M -165.60000M
Discontinued operations - - - 15.20M -0.40000M
Net income from continuing ops 760.10M 599.40M 466.40M 350.70M 517.60M
Net income applicable to common shares 564.70M 452.90M 349.60M 269.80M 412.20M
Preferred stock and other adjustments - - - - -
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Total assets 7089.70M 6534.70M 6102.40M 5636.50M 6864.90M
Intangible assets 308.30M 297.80M 278.20M 282.30M 417.50M
Earning assets - - - - -
Other current assets 141.60M 202.70M 88.40M 127.00M 121.20M
Total liab 3813.90M 3685.50M 3805.20M 3774.60M 4465.70M
Total stockholder equity 2438.20M 2067.00M 1647.50M 1310.30M 1911.30M
Deferred long term liab - - - - 86.70M
Other current liab 588.10M 505.10M 437.50M 309.20M 219.70M
Common stock 1.20M 1.20M 1.20M 1.10M 1.10M
Capital stock 1.20M 1.20M 1.20M 1.10M 1.10M
Retained earnings 1289.40M 796.70M 406.50M 115.70M 141.80M
Other liab - - - 257.20M 259.90M
Good will 1317.60M 1284.00M 1281.30M 1263.20M 2427.90M
Other assets 140.10M 219.20M 0.00000M 222.10M 254.50M
Cash 102.90M 85.40M 104.20M 21.80M 54.80M
Cash and equivalents 72.20M 85.40M 69.10M 21.80M 54.80M
Total current liabilities 836.40M 841.00M 656.40M 575.90M 748.80M
Current deferred revenue - - 42.60M 83.00M 310.30M
Net debt 2611.00M 2628.40M 2828.60M 2970.50M 3483.40M
Short term debt 70.10M 164.90M 48.90M 50.80M 81.20M
Short long term debt 43.60M 138.60M 24.80M 25.20M 42.80M
Short long term debt total 2713.90M 2713.80M 2932.80M 2992.30M 3538.20M
Other stockholder equity 1147.10M 1269.10M 1239.80M 1193.50M 1768.40M
Property plant equipment 4314.20M 3846.80M 3509.50M 3151.70M 2843.60M
Total current assets 905.90M 886.90M 841.80M 717.20M 921.40M
Long term investments - - - - -
Net tangible assets - - - -235.20000M -934.10000M
Short term investments 42.20M 39.00M 37.60M - -
Net receivables 619.20M 598.80M 611.60M 536.80M 680.30M
Long term debt 2447.20M 2359.20M 2687.80M 2741.80M 3243.90M
Inventory - - 72.70M 31.60M 65.10M
Accounts payable 178.20M 171.00M 170.00M 132.90M 137.60M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - 445.70M
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income 0.50M - - - -
Additional paid in capital - - - - -
Common stock total equity - - - - 1.10M
Preferred stock total equity - - - - -
Retained earnings total equity - - - - 141.80M
Treasury stock - - - - -521.20000M
Accumulated amortization - - - - -
Non currrent assets other 114.60M 96.70M 82.10M 139.10M 254.50M
Deferred long term asset charges - - - - -
Non current assets total 6183.80M 5647.80M 5260.60M 4919.30M 5943.50M
Capital lease obligations 223.10M 216.00M 220.20M 225.30M 251.50M
Long term debt total 2447.20M 2359.20M 2687.80M 2741.80M 3243.90M
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Investments - -653.30000M -601.10000M -627.00000M -666.30000M
Change to liabilities - - - 2.30M 14.90M
Total cashflows from investing activities -762.80000M -653.30000M -602.80000M -627.00000M -666.30000M
Net borrowings -29.00000M -242.00000M -83.30000M -498.20000M -66.30000M
Total cash from financing activities -433.00000M -330.60000M -197.20000M -145.70000M -240.10000M
Change to operating activities - - - -15.80000M -68.60000M
Net income 567.20M 599.40M 361.60M 365.90M 517.60M
Change in cash -20.20000M 18.90M 50.80M -66.90000M -190.60000M
Begin period cash flow 123.10M 104.20M 53.40M 120.30M 310.90M
End period cash flow 102.90M 123.10M 104.20M 53.40M 120.30M
Total cash from operating activities 1175.60M 1002.80M 850.80M 705.80M 715.80M
Issuance of capital stock - - - - -
Depreciation 327.90M 299.60M 273.90M 243.60M 256.60M
Other cashflows from investing activities -14.80000M -7.20000M 3.30M -42.90000M 3.50M
Dividends paid 71.10M 62.80M 60.40M 99.00M 112.40M
Change to inventory - - - - -
Change to account receivables -15.20000M 3.00M -22.40000M -16.90000M -64.30000M
Sale purchase of stock -158.00000M -31.10000M -8.20000M 0.00000M -6.10000M
Other cashflows from financing activities -174.90000M 5.30M -45.30000M 703.30M 203.60M
Change to netincome - - - 211.90M 157.20M
Capital expenditures 736.40M 642.50M 583.10M 584.10M 551.20M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -190.60000M
Change in working capital 4.30M 21.90M 50.30M -30.40000M -118.00000M
Stock based compensation 56.50M 48.30M 50.60M 29.20M 32.80M
Other non cash items 253.90M 22.90M 110.50M 69.60M -1.00000M
Free cash flow 439.20M 360.30M 267.70M 121.70M 164.60M

Peer Comparison

Sector: Healthcare Industry: Medical Care Facilities

Company Change (USD) Price (USD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
EHC
Encompass Health Corp		 -2.9 2.79% 101.11 19.17 17.06 1.74 4.33 2.23 9.41
HCA
HCA Healthcare, Inc.		 -10.81 2.90% 361.32 13.19 13.66 1.13 293.44 1.77 8.22
FSNUY
Fresenius SE & Co KGaA ADR		 -0.11 1.02% 10.69 16.87 9.44 0.42 0.78 0.79 5.37
JDHIY
JD Health International Inc		 - -% 5.33 62.50 35.97 0.30 2.32 0.16 3.90
JDHIF
JD Health International Inc		 - -% 5.85 57.75 32.68 0.29 2.11 0.16 3.90

Reports Covered

Stock Research & News

View All

Profile

Encompass Health Corporation operates inpatient rehabilitation hospitals in the United States and Puerto Rico. The company offers specialized rehabilitative treatment, using technology and therapy, on an inpatient basis for patients recovering from a major injury or illness and seeking to regain functional ability, independence, and quality of life; medical, nursing, therapy, and ancillary services; and rehabilitative care to patients who are recovering from conditions, such as stroke and other neurological disorders, cardiac and pulmonary conditions, brain and spinal cord injuries, complex orthopedic conditions, and amputations. It offers services through the Medicare program to the federal government, managed care plans and private insurers, state governments, and other patients. The company was formerly known as HealthSouth Corporation and changed its name to Encompass Health Corporation in January 2018. Encompass Health Corporation was incorporated in 1984 and is based in Birmingham, Alabama.

Encompass Health Corp

9001 Liberty Parkway, Birmingham, AL, United States, 35242

Key Executives

Name Title Year Born
Mr. Mark J. Tarr CEO, Pres & Director 1962
Mr. Douglas E. Coltharp Exec. VP & CFO 1962
Mr. John Patrick Darby Exec. VP, Gen. Counsel & Corp. Sec. 1965
Ms. Elissa Joy Charbonneau Chief Medical Officer 1960
Mr. Andrew L. Price Sr. VP & Chief Accounting Officer 1967
Mr. Rusty Yeager Chief Information Officer & Sr. VP NA
Mr. Mark Miller Sr. VP of Investor Relations & Strategic Planning NA
Ms. Dawn Rock Chief Compliance Officer NA
Mr. Anthony A. Hernandez Chief HR Officer 1966
Mr. Frank Brown Pres of Southwest Region NA

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.